What is the recommended dose and duration of trimethoprim‑sulfamethoxazole (Bactrim) for treating an adult Escherichia coli wound infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bactrim Dosing for E. coli Wound Infection

For an adult E. coli wound infection, use trimethoprim-sulfamethoxazole (Bactrim) 1-2 double-strength tablets (160/800 mg) twice daily for 7-10 days.

Dosing Rationale

The FDA-approved dosing for skin and soft tissue infections is 1 BACTRIM DS (double strength) tablet or 2 BACTRIM tablets every 12 hours 1. For wound infections, a 7-10 day course is appropriate based on standard SSTI treatment duration 2.

Specific Dosing Options:

  • Standard dose: 160/800 mg (1 DS tablet) twice daily
  • High dose: 320/1,600 mg (2 DS tablets) twice daily for more severe infections

The higher dose does not improve clinical outcomes for most SSTIs. Research comparing these regimens in MRSA skin infections found no difference in clinical resolution (73% vs 75%, p=0.79) between high-dose and standard-dose treatment 3. Therefore, start with standard dosing unless the infection is severe or the patient is immunocompromised.

Clinical Context from Guidelines

The IDSA skin and soft tissue infection guidelines 2 list trimethoprim-sulfamethoxazole as an option for wound infections with several important caveats:

  • Good activity against aerobic bacteria including E. coli
  • Poor activity against anaerobes - if the wound is contaminated with bowel flora or has anaerobic involvement (foul odor, necrotic tissue, deep tissue involvement), add metronidazole 500 mg every 8 hours or choose a different agent
  • Bactericidal against gram-negative organisms like E. coli 2

Treatment Duration

7-10 days is standard for uncomplicated wound infections 2. Extend to 10-14 days if:

  • Slow clinical response
  • Significant surrounding cellulitis
  • Immunocompromised host
  • Deep tissue involvement

Critical Pitfalls

  1. Anaerobic coverage gap: Bactrim has poor anaerobic activity 2. For wounds near the perineum, axilla, or involving bowel contamination, use combination therapy or switch to amoxicillin-clavulanate.

  2. MRSA consideration: While Bactrim covers MRSA, if Staphylococcus aureus is suspected or isolated, verify susceptibility testing before continuing 2.

  3. Adverse effects: Bactrim carries higher risk of rash (2.56-fold increased risk), Stevens-Johnson syndrome, blood dyscrasias (pancytopenia, neutropenia), and electrolyte abnormalities (hyperkalemia, hyponatremia) compared to other antibiotics 4. Monitor for rash and consider CBC if treatment exceeds 10 days.

  4. Renal dosing: Adjust for creatinine clearance <30 mL/min - use half the usual dose for CrCl 15-30 mL/min, and avoid if CrCl <15 mL/min 1.

When to Choose Alternative Therapy

Consider amoxicillin-clavulanate 875/125 mg twice daily instead if:

  • Wound involves perineum, axilla, or areas with anaerobic risk
  • Mixed flora suspected
  • Patient has sulfa allergy
  • Concern for severe adverse reactions given Bactrim's safety profile 4

Related Questions

Which component of the combination antibiotic trimethoprim‑sulfamethoxazole (Bactrim) is used to calculate the dose?
In a patient without a sulfa allergy, is trimethoprim‑sulfamethoxazole (TMP‑SMX) an appropriate choice for treating an Escherichia coli infection after amoxicillin‑clavulanate (Clavamox) has failed?
Is trimethoprim‑sulfamethoxazole (Bactrim) effective for treating Moraxella infections?
What is the best antibiotic to treat a patient with a urine culture showing bacteriuria (presence of bacteria in the urine) with 10,000-20,000 colony-forming units (CFU) per milliliter and no predominant bacteria?
What is the appropriate dosage of Bactrim (trimethoprim‑sulfamethoxazole) for a patient with a foot abscess after surgical debridement?
What should the employer letter state regarding work restrictions for a patient with a suspected meniscal tear that limits weight‑bearing, knee flexion, twisting, and walking on hills or uneven surfaces?
Is a single dose of Rocephin (ceftriaxone) adequate for treating an E. coli wound infection?
What is the likely diagnosis and recommended management for a patient whose chest CT shows few small air‑space opacifications with surrounding centrilobular nodules in the right upper lobe and left lower lobe, volume loss in the medial segment of the right middle lobe, mild cylindrical bronchiectasis in the bilateral lower lobes and right upper lobe posterior segment, and mildly enlarged pre‑/paratracheal and carinal mediastinal lymph nodes?
Which NSAID provides the greatest renal and gastrointestinal safety?
What management recommendations are appropriate for a 68-year-old woman with normal cardiac evaluation, a coronary calcium score of 4 (no coronary artery disease), persistent angina, intolerance to isosorbide mononitrate, amlodipine, and metoprolol, and relief with sublingual nitroglycerin?
A 28-year-old woman with measles IgG 66.40 IU, mumps IgG 90 IU, rubella IgG 0.94 IU, and varicella titer <1:4—does she require any vaccinations?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.